EGFR and lung carcinoma: Although previous studies have reported that ESB triggered apoptosis and cell cycle arrest and inhibited the migration and invasion of human lung cancer cells [21,22,23,24], they did not focus on the activity of ESB in EGFR TKI-resistant cell lines.